ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

South Korea signs COVID vaccine deals for 44m people

Government to buy 20m doses each from AstraZeneca, Pfizer and Moderna

SEOUL (Reuters) -- South Korea said on Tuesday it had signed deals to provide coronavirus vaccines for 44 million people next year, as the country battles a wave of infections that authorities say could overwhelm its medical system.

The government has arranged to buy 20 million doses each from AstraZeneca Plc, Pfizer Inc, and Moderna Inc, and another 4 million doses from Johnson & Johnson's Janssen, enough to cover up to 34 million people, Health Minister Park Neung-hoo told a briefing.

Additional doses for 10 million people would be procured through the World Health Organization's global vaccine project, known as COVAX, he added.

"We had initially planned to secure vaccines for 30 million people but decided to purchase more, as there is uncertainty over the success of the vaccine candidates and the competition is intense among countries for early purchases," he said.

Shipments of the vaccine would begin no later than March, but authorities would observe how the vaccines worked in other countries for several months to ensure safety. Widespread vaccination was likely to begin in the second half of next year.

Despite the current surge in cases, South Korea's relative success in tamping down previous waves meant the government did not need to rush a vaccine, Park said.

"We don't see the need to hurriedly begin vaccination without ensuring that the vaccines' risks have been verified," he said.

The first vaccines would likely go to medical workers, elderly and medically vulnerable people, and social workers.

The Korea Disease Control and Prevention Agency reported 594 new coronavirus cases as of midnight Monday, bringing the country's total to 38,755, with 552 deaths.

Unlike South Korea's previous two waves of infections, which were largely focused around a handful of facilities or events, the new wave is being driven by smaller, harder-to-trace clusters in and around the densely populated capital city of Seoul.

Vice Health Minister Kang Do-tae said the government had been unable to trace the origin of 26% of all cases, and the positivity rate spiked nearly fourfold within a month to about 4%.

"If social distancing is not implemented properly, outbreaks in the greater Seoul area would lead to greater transmissions nationwide," Kang told a meeting of health officials according to a transcript from the health ministry.

Health authorities predicted daily cases would hover between 550 and 750 this week, and possibly spike to as much as 900 next week.

If such predictions are accurate, Kang said the country's health system may collapse.

"There could be a dangerous situation where it becomes difficult not only to treat COVID-19 patients but also to provide essential medical services," he said.

South Korean President Moon Jae-in called on Monday for expanded coronavirus testing and more thorough tracing as infections continued to rise despite the imposition of increasingly restrictive social distancing measures.

Seoul was not currently in talks to buy vaccines from either Russia or China, Park said.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends January 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more